6CMB Stock Overview
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Croda International Plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£56.50 |
52 Week High | UK£80.00 |
52 Week Low | UK£46.60 |
Beta | 0.71 |
1 Month Change | -0.88% |
3 Month Change | -3.42% |
1 Year Change | -22.07% |
3 Year Change | -24.16% |
5 Year Change | n/a |
Change since IPO | 540.06% |
Recent News & Updates
Recent updates
Shareholder Returns
6CMB | DE Chemicals | DE Market | |
---|---|---|---|
7D | 2.7% | 2.2% | 2.5% |
1Y | -22.1% | 6.5% | 7.0% |
Return vs Industry: 6CMB underperformed the German Chemicals industry which returned 7.1% over the past year.
Return vs Market: 6CMB underperformed the German Market which returned 7.3% over the past year.
Price Volatility
6CMB volatility | |
---|---|
6CMB Average Weekly Movement | 4.9% |
Chemicals Industry Average Movement | 4.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6CMB has not had significant price volatility in the past 3 months.
Volatility Over Time: 6CMB's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1925 | 5,852 | Steve Foots | https://www.croda.com |
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations.
Croda International Plc Fundamentals Summary
6CMB fundamental statistics | |
---|---|
Market cap | €7.91b |
Earnings (TTM) | €199.61m |
Revenue (TTM) | €1.98b |
39.6x
P/E Ratio4.0x
P/S RatioIs 6CMB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6CMB income statement (TTM) | |
---|---|
Revenue | UK£1.69b |
Cost of Revenue | UK£964.50m |
Gross Profit | UK£730.00m |
Other Expenses | UK£559.00m |
Earnings | UK£171.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 30, 2024
Earnings per share (EPS) | 1.23 |
Gross Margin | 43.08% |
Net Profit Margin | 10.09% |
Debt/Equity Ratio | 26.4% |
How did 6CMB perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yield89%
Payout RatioDoes 6CMB pay a reliable dividends?
See 6CMB dividend history and benchmarksCroda International dividend dates | |
---|---|
Ex Dividend Date | Apr 18 2024 |
Dividend Pay Date | May 29 2024 |
Days until Ex dividend | 21 days |
Days until Dividend pay date | 62 days |
Does 6CMB pay a reliable dividends?
See 6CMB dividend history and benchmarks